Table of Contents

company-logo

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Edwards Lifesciences Dividend Announcement

• Edwards Lifesciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Edwards Lifesciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Edwards Lifesciences Dividend History

Edwards Lifesciences Dividend Yield

Edwards Lifesciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Edwards Lifesciences stock? Use our calculator to estimate your expected dividend yield:

Edwards Lifesciences Financial Ratios

P/E ratio9.55
PEG ratio0.61
P/B ratio4.16
ROE54.10%
Payout ratio0.00%
Current ratio3.46
Quick ratio2.89
Cash Ratio1.89

Edwards Lifesciences Dividend FAQ

Does Edwards Lifesciences stock pay dividends?
Edwards Lifesciences does not currently pay dividends to its shareholders.
Has Edwards Lifesciences ever paid a dividend?
No, Edwards Lifesciences has no a history of paying dividends to its shareholders. Edwards Lifesciences is not known for its dividend payments.
Why doesn't Edwards Lifesciences pay dividends?
There are several potential reasons why Edwards Lifesciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Edwards Lifesciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Edwards Lifesciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Edwards Lifesciences a dividend aristocrat?
Edwards Lifesciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Edwards Lifesciences a dividend king?
Edwards Lifesciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Edwards Lifesciences a dividend stock?
No, Edwards Lifesciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Edwards Lifesciences stocks?
To buy Edwards Lifesciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Edwards Lifesciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.